Skip to main content

Remote Job Finders (RJF)

Massachusetts R&D, Biomanufacturing Jobs Fell in ’24: Report

Massachusetts biopharma workforce growth was fairly flat last year, and R&D and manufacturing employment declined, according to a new MassBio report. BioSpace data further highlight challenges facing the state, showing roughly 2,300 people out of work in 2025 and jobs live on the website falling.

Amylyx Axes Drug Program for Rare Neurodegenerative Disorder

AMX0035—approved as Relyvrio in 2022 for amyotrophic lateral sclerosis but voluntarily pulled from the market last year—was unable to distinguish itself from placebo in a mid-to-late-stage trial of progressive supranuclear palsy.
Scroll to top